Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rheumatoid Arthritis
100%
Sjgren's Syndrome
42%
Primary Sjgren Syndrome
40%
European League against Rheumatism (EULAR)
32%
Sicca
29%
Placebo
25%
Clinical Trials
24%
Disease Activity Score
24%
Randomized Double-blind
21%
Autoimmune Disease
20%
Tertiary Lymphoid Structures
20%
Disease Activity
18%
Dryness
16%
Autoimmunity
16%
Sjögren's Disease
16%
Salivary Gland
14%
Citrullinated
14%
Sjögren's Syndrome
14%
Rheumatology
13%
Randomized Placebo-controlled Trial
13%
Systemic Autoimmune Diseases
13%
Immune Checkpoint Inhibitors
13%
Classification Criteria
13%
B Cells
13%
Anti-citrullinated Protein Antibodies
12%
Etiology
12%
Minor Salivary Gland Biopsy
12%
Immune Response
12%
Porphyromonas Gingivalis (P. gingivalis)
12%
Placebo-controlled
11%
Infliximab
11%
Arthritis
11%
Randomized Clinical Trial
11%
Inflammatory Arthritis
11%
Abatacept
11%
Vimentin
10%
Enolase
10%
Anti-cyclic Citrullinated Peptide (anti-CCP)
10%
COVID-19
10%
Standard of Care
10%
Trial Protocol
10%
Interferon-α (IFN-α)
10%
British Society for Rheumatology
10%
Dose-ranging Study
10%
Iscalimab
10%
Control Phase
10%
Nuclease
10%
Proof of Concept Study
10%
Southern European
10%
Ultrasound
10%
Medicine and Dentistry
Diseases
49%
Inflammatory Arthritis
48%
Rheumatoid Arthritis
48%
Disease Activity
43%
Salivary Gland
35%
Clinical Trial
32%
Rheumatology
30%
Placebo
28%
Rheumatic Disease
25%
COVID-19
20%
Biological Marker
19%
Sjoegren Syndrome
18%
C Reactive Protein
14%
Echography
14%
Rituximab
14%
Glucocorticoid
14%
Arm
14%
Infliximab
13%
Arthritis
12%
Disease-Modifying Antirheumatic Drug
11%
Immune Checkpoint Inhibitor
11%
Randomized Controlled Trial
11%
Immune Response
10%
Steroids
10%
Systematic Review
10%
Salivary Gland Biopsy
10%
Namilumab
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Histopathology
10%
Ianalumab
10%
Cohort Analysis
10%
Infection
9%
Abatacept
9%
Myositis
8%
Quality of Life
8%
Oral
8%
B Cell
7%
Therapeutic Management
7%
Topical Treatment
7%
Systemic Therapy
7%
Dermatomyositis
7%
Pneumonia
7%
Autoimmunity
7%
Methotrexate
7%
Meta-Analysis
7%
Adverse Event
6%
Autoimmune Disease
6%
Controlled Clinical Trial
6%
Randomized Clinical Trials
6%
Autoantibodies
6%
Immunology and Microbiology
Inflammatory Arthritis
93%
Autoimmunity
50%
Sjögren's Syndrome
40%
Salivary Gland
34%
Peptides
32%
Autoantibodies
22%
Arthritis
19%
Immune Response
18%
Autoimmune Disease
18%
Immune Checkpoint Inhibitor
17%
interferon
15%
Tertiary Lymphoid Structure
15%
Glucocorticoid
15%
B Cell
14%
Inflammation
13%
Autoantigen
13%
Porphyromonas gingivalis
12%
Antigen
10%
Tumor Necrosis Factor
10%
Iscalimab
10%
Rituximab
10%
Programmed Death-Ligand 1
10%
Myositis
10%
Fatty Acid
10%
Epitope
9%
Lung
9%
Citrullination
8%
Exocrine Gland
8%
Abatacept
8%
Belimumab
8%
Sialadenitis
8%
Blood Level
8%
Germinal Center
8%
Fibroblast
7%
Inflammatory Disorder
7%
Systemic Autoimmune Disease
7%
Systemic Lupus Erythematosus
7%
Immune Tolerance
7%
Phosphotransferase
7%
Kinase
7%
HLA DRB1 Antigen
7%
Chemokine
7%
Therapeutic Target
7%
B Cell Activation
7%
Proteomics
6%
Autoimmune Rheumatic Disease
6%
Cytokine
6%
Fibrinogen
5%
Etanercept
5%
Peripheral Nervous System
5%